Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
Finland
Meilahti Vaccine Research Center, Helsinki University Central Hospital, Helsinki Age range
18 Years – 90 Years
Last updated September 2023